“…Medications examined included amitriptyline, 16-18 trimipramine, 19 imipramine, 20 milnacipran, 21 sertraline, 22 dotheipin, 23,24 and duloxetine 25 (Tables 1 and 2). Among these studies only 4 specifically targeted patients with RA and depression in the inclusion criteria, 17,19,22,23 seven assessed change in mental health outcome measures, 17-20,22-24 none accounted for diagnosis of comorbid fibromyalgia or neuropathy, and 1 assessed change in fibromyalgia symptom severity. 21 Additionally, only 2 studies reported if patients were in disease remission or well controlled inflammation.…”